Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
The Journal of Pediatrics
|
October 1, 1991
Risk factors for major neurodevelopmental impairments and need for special education resources in extremely premature infants
M E Msall, G M Buck, B T Rogers, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
August 2, 2022
Strain-Driven Mixed-Phase Domain Architectures and Topological Transitions in Pb<sub>1-</sub> <sub>x</sub> Sr<sub>x</sub> TiO<sub>3</sub> Thin Films
Pravin Kavle, Jacob A Zorn, Arvind Dasgupta, et al.
Elife
|
February 21, 2015
Autoinhibition of Bruton's tyrosine kinase (Btk) and activation by soluble inositol hexakisphosphate
Qi Wang, Erik M Vogan, Laura M Nocka, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP
|
April 1, 1992
Parents' developmental perceptions and expectations for their high-risk infants
B T Rogers, L J Booth, L C Duffy, et al.
Development (Cambridge, England)
|
November 11, 1999
Single cells can sense their position in a morphogen gradient
J B Gurdon, H Standley, S Dyson, et al.
Blood Pressure Monitoring
|
August 24, 2001
Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor
J M Wright, G S Mattu, T L Perry, et al.
The Journal of General Virology
|
March 22, 2007
Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds
Puay-Wah Phuan, Julie A Zorn, Jiri Safar, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
January 1, 1994
Multivariate risks among extremely premature infants
M E Msall, G M Buck, B T Rogers, et al.
Journal of Medicinal Chemistry
|
January 5, 2007
Structure-activity relationship study of prion inhibition by 2-aminopyridine-3,5-dicarbonitrile-based compounds: parallel synthesis, bioactivity, and in vitro pharmacokinetics
Barnaby C H May, Julie A Zorn, Juanita Witkop, et al.
Cancer Immunology Research
|
August 18, 2022
Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab
Kent Thudium, Mark Selby, Julie A Zorn, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
The Journal of Pediatrics
|
October 1, 1991
Risk factors for major neurodevelopmental impairments and need for special education resources in extremely premature infants
M E Msall, G M Buck, B T Rogers, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
August 2, 2022
Strain-Driven Mixed-Phase Domain Architectures and Topological Transitions in Pb<sub>1-</sub> <sub>x</sub> Sr<sub>x</sub> TiO<sub>3</sub> Thin Films
Pravin Kavle, Jacob A Zorn, Arvind Dasgupta, et al.
Elife
|
February 21, 2015
Autoinhibition of Bruton's tyrosine kinase (Btk) and activation by soluble inositol hexakisphosphate
Qi Wang, Erik M Vogan, Laura M Nocka, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP
|
April 1, 1992
Parents' developmental perceptions and expectations for their high-risk infants
B T Rogers, L J Booth, L C Duffy, et al.
Development (Cambridge, England)
|
November 11, 1999
Single cells can sense their position in a morphogen gradient
J B Gurdon, H Standley, S Dyson, et al.
Blood Pressure Monitoring
|
August 24, 2001
Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor
J M Wright, G S Mattu, T L Perry, et al.
The Journal of General Virology
|
March 22, 2007
Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds
Puay-Wah Phuan, Julie A Zorn, Jiri Safar, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
January 1, 1994
Multivariate risks among extremely premature infants
M E Msall, G M Buck, B T Rogers, et al.
Journal of Medicinal Chemistry
|
January 5, 2007
Structure-activity relationship study of prion inhibition by 2-aminopyridine-3,5-dicarbonitrile-based compounds: parallel synthesis, bioactivity, and in vitro pharmacokinetics
Barnaby C H May, Julie A Zorn, Juanita Witkop, et al.
Cancer Immunology Research
|
August 18, 2022
Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab
Kent Thudium, Mark Selby, Julie A Zorn, et al.
Page
of 5